stock.name

Kindred Biosciences Inc

KIN

Market Cap$0
Close$

Compare Kindred Biosciences

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Kindred Biosciences IncKindred Biosciences Inc00%---
marketMarket Avg59.61.27%31%6.41
HealthcareHealthcare Avg62.31.27%15%7.30.9
$9.55

Current Fair Value

3.2% upside

Undervalued by 3.2% based on the discounted cash flow analysis.

Share Statistics

Market cap$0.00
Enterprise Value-
Dividend Yield$0.0 (0.0%)
Earnings per Share$0.0
Beta0.0
Outstanding Shares45,462,318
Avg 30 Day Volume0

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio0.0
PEG-
Price to Sales-
Price to Book Ratio-
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income-
Total Debt to Enterprise-
Debt to Equity-

Revenue Sources

No data

ESG Score

No data

About Kindred Biosciences Inc

140 employees
CEO: Richard Chin

Kindred Biosciences is a biopharmaceutical company developing innovative biologics focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family member...